Skip to main content
Premium Trial:

Request an Annual Quote

Don Elsey

OpGen has appointed Don Elsey to its board of directors and as the chairman of its audit committee. Elsey previously served as chief financial officer of Senseonics from 2015 to 2019. Prior to Senseonics, Elsey served as CFO of Regado Biosciences. He as also served as CFO of LifeCell and Emergent Biosolutions. In addition, Elsey has held senior financial positions at BioVeris, Igen, and PE (Applera). 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.